抗病毒治疗对乙型肝炎病毒感染者肾移植术后临床转归的影响
2015-01-31董宇
董宇
抗病毒治疗对乙型肝炎病毒感染者肾移植术后临床转归的影响
董宇
【摘要】目的 探讨乙型肝炎病毒感染者肾移植术后采用抗病毒治疗对临床转归的影响。方法 选取2010年5月~2015年5月我院收治乙型肝炎病毒感染者肾移植术患者30例,采用抗病毒治疗。结果 选取的抗病毒治疗患者30例,存活率为83.3%,死亡率为16.7%。2例死于肝功能衰竭,3例肝硬化失代偿及肝癌行肝肾联合移植,后出现肝衰竭死亡。结论 针对乙肝病毒感染者,在实施肾移植术后,应用抗乙肝病毒药物,可对病毒复制水平抑制,使肝功能复常率提高。在应用拉米夫定过程中,若有病毒学反弹情况出现,可取阿德福韦酯挽救治疗,以促病情好转,改善预后。
【关键词】抗病毒治疗;乙型肝炎病毒感染;肾移植术后;临床转归
作者单位:466001河南省周口市中心医院感染科
The Clinical Outcome Influence of Antiviral Therapy for Hepatitis Virus B Infection After Renal Transplantation
DONG Yu Zhoukou City Centre Hospital Infection Department in He’nan Province, Zhoukou 466001, China
[Abstract]Objective To explore the effect of antiviral therapy on the prognosis of hepatitis B virus infected patients after renal transplantation. Methods Selected 30 patients with hepatitis B virus infection May 2010 to May 2015 were treated by renal transplantation. Results 30 patients were treated with anti-virus therapy, the survival rate was 83.3%, the mortality was 16.7%. Died of hepatic failure in 2 cases, cirrhosis and liver cirrhosis and liver cancer combined liver and kidney transplantation, liver failure occurred after death in 3 cases. Conclusion For patients with hepatitis B virus infection, after the implementation of renal transplantation, hepatitis B virus drug application can be use to inhibit viral replication, the liver function recovery rate is improve. In the course of lamivudine, if virological rebound appears, desirable rescue treatment of adefovir dipivoxil, to promote the condition improved, to the greatest extent improve prognosis. [Key words] Antiviral therapy, Hepatitis B virus infection, Renal transplantation, Clinical outcome
乙型病毒也称乙肝病毒,相关资料表明[1]乙肝病毒在肝内繁殖复杂,但对肝细胞没有直接损伤效果。多项研究表明[2],相较非肝炎病毒感染者,肝炎病毒感染者肾移植后远期生存率处于较低水平,特别是HBV感染者,有较高术后早期病死率,死因主要为继发感染和肝功能衰竭。针对乙肝病毒感染的肾移植病例,制定合理治疗方案是提高长期存活率、避免肝功能损害、肝炎复发的关键。探讨抗病毒治疗对此类患者临床转归的影响,具体报道如下。
1 资料与方法
1.1 一般资料
选取乙型肝炎病毒感染肾移植术患者30例,其中男28例,女2例,年龄24~68岁,平均(43.2±1.9)岁。……
